Drugs / Luteolin
Luteolin
also known as
Cyanidenon-1470 · Digitoflavone · Flacitran · Luteoline · Luteolol · Salifazide · Weld lake · Yama kariyasu
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03288298 | Nov 2017 → Sep 2018 | carcinoma, tongue neoplasm | Cairo University | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04853836 | Nov 2020 → Oct 2021 | COVID-19, anosmia | University Of Perugia | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Luteolin | “The studies evaluated the following interventions: systemic corticosteroids plus intranasal corticosteroid/mucolytic/decongestant and palmitoylethanolamide plus luteolin.” PMID 36062970 ↗ Sep 2022 |
| Known as | Cyanidenon-1470 | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Digitoflavone | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Flacitran | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Luteoline | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Luteolol | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Salifazide | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Weld lake | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Known as | Yama kariyasu | ChEMBL registry synonym — accepted as the source's own label CHEMBL151 ↗ |
| Modality | Small molecule | — CHEMBL151 ↗ |
| Route | Oral | “daily oral tablet that contained PEA 700 mg and Luteolin 70 mg” NCT04853836 ↗ |